Peer-reviewedCC BY 4.0Journal of Clinical Medicine
Comment on Sun et al. First Experience with Hypothermic Oxygenated Perfusion in Human Uteri: Feasibility and Metabolic Characterization. J. Clin. Med. 2026, 15, 2820
Abstract
We read with great interest the recent article by Sun et al. describing the first application of hypothermic oxygenated perfusion (HOPE) in human uteri, titled “First Experience with Hypothermic Oxygenated Perfusion in Human Uteri: Feasibility and Metabolic Characterization” by Keyue Sun et al [1], published on 8 April 2026. This innovative work represents a major step forward in improving graft preservation and viability assessment in uterus transplantation (UTx), particularly in the context of deceased donors, where prolonged ischemia remains a critical limitation; around 6 h in the case of a deceased donor, compared with 2.3 h in the case of a living donor...
Related
- Hypothermic and Normothermic Machine Perfusion Differentially Shape the Renal Cellular Landscape
- Hypothermic Conditions Impair GnRH Pulse Generator Activity and Gametogenesis
- Dynamic contrast enhanced MRI demonstrate altered placental perfusion in the STOX1A preeclampsia mouse model
- Vascular tree structure-based perfusion phantom fabrication using modified Hele-Shaw cell method
- WITHDRAWN: Segmental Variability of Bolus-dispersion-induced Myocardial Blood Flow in Quantitative Myocardial Perfusion MRI: A CFD-based Analysis
BibTeX
@article{dion2026comment,
title = {{Comment on Sun et al. First Experience with Hypothermic Oxygenated Perfusion in Human Uteri: Feasibility and Metabolic Characterization. J. Clin. Med. 2026, 15, 2820}},
author = {Ludivine Dion and C. Sousa and Margot Dugast and Vincent Lavoué},
journal = {Journal of Clinical Medicine},
year = {2026},
month = jun,
doi = {10.3390/jcm15124695},
url = {https://hal.science/hal-05675595v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Comment on Sun et al. First Experience with Hypothermic Oxygenated Perfusion in Human Uteri: Feasibility and Metabolic Characterization. J. Clin. Med. 2026, 15, 2820
AU - Ludivine Dion
AU - C. Sousa
AU - Margot Dugast
AU - Vincent Lavoué
PY - 2026
DA - 2026/06/17
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15124695
UR - https://hal.science/hal-05675595v1
AB - We read with great interest the recent article by Sun et al. describing the first application of hypothermic oxygenated perfusion (HOPE) in human uteri, titled “First Experience with Hypothermic Oxygenated Perfusion in Human Uteri: Feasibility and Metabolic Characterization” by Keyue Sun et al [1], published on 8 April 2026. This innovative work represents a major step forward in improving graft preservation and viability assessment in uterus transplantation (UTx), particularly in the context of deceased donors, where prolonged ischemia remains a critical limitation; around 6 h in the case of a deceased donor, compared with 2.3 h in the case of a living donor...
SN - 2077-0383
ER -